On Friday, Amneal Pharmaceuticals Inc (NASDAQ: AMRX) opened higher 1.42% from the last session, before settling in for the closing price of $8.46. Price fluctuations for AMRX have ranged from $3.36 to $8.95 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 7.85% over the past five years. Company’s average yearly earnings per share was noted -6.52% at the time writing. With a float of $119.85 million, this company’s outstanding shares have now reached $306.56 million.
Let’s look at the performance matrix of the company that is accounted for 7850 employees. In terms of profitability, gross margin is 35.04%, operating margin of 6.72%, and the pretax margin is -4.45%.
Amneal Pharmaceuticals Inc (AMRX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Amneal Pharmaceuticals Inc is 61.28%, while institutional ownership is 39.32%. The most recent insider transaction that took place on Aug 15 ’24, was worth 315,766. In this transaction Executive Vice President of this company sold 40,225 shares at a rate of $7.85, taking the stock ownership to the 256,670 shares. Before that another transaction happened on Aug 14 ’24, when Company’s Executive Vice President sold 22,486 for $7.81, making the entire transaction worth $175,616. This insider now owns 296,895 shares in total.
Amneal Pharmaceuticals Inc (AMRX) Latest Financial update
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted 0.19 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 0.13) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -6.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 3.00% during the next five years compared to -23.74% drop over the previous five years of trading.
Amneal Pharmaceuticals Inc (NASDAQ: AMRX) Trading Performance Indicators
Check out the current performance indicators for Amneal Pharmaceuticals Inc (AMRX). In the past quarter, the stock posted a quick ratio of 0.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.02. Likewise, its price to free cash flow for the trailing twelve months is 59.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.62, a number that is poised to hit 0.13 in the next quarter and is forecasted to reach 0.70 in one year’s time.
Technical Analysis of Amneal Pharmaceuticals Inc (AMRX)
Amneal Pharmaceuticals Inc (NASDAQ: AMRX) saw its 5-day average volume 0.81 million, a negative change from its year-to-date volume of 1.44 million. As of the previous 9 days, the stock’s Stochastic %D was 36.38%. Additionally, its Average True Range was 0.25.
During the past 100 days, Amneal Pharmaceuticals Inc’s (AMRX) raw stochastic average was set at 86.09%, which indicates a significant increase from 41.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.89% in the past 14 days, which was lower than the 34.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.42, while its 200-day Moving Average is $6.77. Nevertheless, the first resistance level for the watch stands at $8.75 in the near term. At $8.91, the stock is likely to face the second major resistance level. The third major resistance level sits at $9.13. If the price goes on to break the first support level at $8.37, it is likely to go to the next support level at $8.15. The third support level lies at $7.99 if the price breaches the second support level.
Amneal Pharmaceuticals Inc (NASDAQ: AMRX) Key Stats
There are currently 308,651K shares outstanding in the company with a market cap of 2.66 billion. Presently, the company’s annual sales total 2,394 M according to its annual income of -83,990 K. Last quarter, the company’s sales amounted to 701,780 K and its income totaled 5,990 K.
